In the plasma, the concentration of YKL-40 was 2 times higher, CT-1 concentration was 2.6 times higher, and OPG concentration was 78% lower when comparing the OSA group to the control group. The gene discussed is CHI3L1; the disease is obstructive sleep apnea syndrome.